For the first time ever in the UK, a gluten-free breakfast cereal will sit alongside other well-known brands in the mainstream cereal aisle, marking a breakthrough in the availability of gluten-free cereal products.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/72762533-nestle-gluten-free-cereal-launch/
Fresh videos, information and links relating to the stress experienced by America's 15 million+ family caregivers for people with dementia are now available in the Brookdale Alzheimer's Resource Center. The new topics include:
A woman describing the impact of her mother-in-law's dementia on her family: Video
How spouses and adult children experience caregiving differently: Video and text document
Ways that caregivers can protect their own brain health: Text document
Long-distance caregiving, the symptoms of caregiving stress, dealing with caregiver guilt, being a healthy caregiver and caring for the caregiver: Links to information and a webinar
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7087731-brookdale-senior-living/
With gout incidence on the rise, an increasing number of medical professionals, across multiple fields of practice, will continue to be exposed to patients who suffer from gout and are seeking an accurate diagnosis and treatment. However, despite the availability of the “Guidelines for the Management of Gout” by the American College of Rheumatology (ACR), there are many inconsistencies in how gout is diagnosed, treated and discussed by medical professionals. Conflicting messages and treatment recommendations can contribute to confusion, and even lack of compliance, on behalf of the patient – particularly when gout is connected with comorbid conditions, such as kidney disease, heart disease or diabetes.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7362551-gout-uric-acid-education-society-guaes-roundtable-consensus-paper/
In support of American Diabetes Month®, Colgate Total kicked-off the “Small Steps Make a Big Difference” campaign to help raise awareness surrounding the often overlooked association between oral health and diabetes.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7332551-colgate-total-american-diabetes-association-small-steps-make-a-big-difference-campaign/
As the number of people living with Alzheimer’s disease soars, so does the number of family caregivers. Over 15 million people are taking care of loved ones with dementia in the home, according to the Alzheimer’s Association. Sixty percent say the emotional stress is high and more than a third report depression symptoms. To help, Brookdale is offering a free webinar for family caregivers during November, National Alzheimer’s Awareness Month. The company, America’s largest provider of dementia care, is also offering a web-based Alzheimer’s Resource Center and other expert information.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7087731-brookdale-senior-living/
Finding time to eat well doesn’t mean you have to resort to eating out or going through the drive through during this busy fall season. New data analysis, supported in part by by Nestlé USA, indicates that people who reported dining on frozen meals ate fewer calories per day and consumed less saturated fat than those who reported eating fast food meals, also known as quick service restaurant (QSR) meals.1 The findings also showed that those who reported eating frozen meals consumed more essential nutrients than those who reported opting for fast food meals.
The findings are based on a new analysis of data from the 2003-2010 What We Eat In America (WWEIA) National Health and Nutrition Examination Survey (NHANES), a program of the Centers for Disease Control and Prevention (CDC).
To view the Multimedia News Release, go http://www.multivu.com/players/English/7349551-nestle-usa-frozen-meal-eaters-consume-fewer-calories-per-day/
OhioHealth “Delay the Disease”, an evidenced-based fitness program designed for people with Parkinson’s Disease, is one of the newest members of the OhioHealth family of neuroscience programs. The community-based wellness program is designed to empower those living with Parkinson’s Disease by optimizing their physical function and helping to delay the progression of symptoms associated with Parkinson’s Disease.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7342451-ohiohealth-delay-the-disease-parkinson-s-disease-fitness-program/
Understanding the burden of metastatic breast cancer (MBC), and the toll it takes on patients and their loved ones, Eisai Inc. announced today the launch of mbcInfoCenter.com, a new online portal designed to provide important resources that may help women with MBC manage their disease and focus on their health and wellness.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7342251-eisai-launches-mbc-infocenter-for-women-with-metastatic-breast-cancer/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
In the United States for 2014, about 62,900 new thyroid cancer cases will be diagnosed. Medullary thyroid cancer – a rare form of cancer located in the thyroid gland at the base of the throat – represents only about three to four percent of all thyroid cancers. Of those cases, just one third will be locally advanced or metastatic disease. With Thyroid Cancer Awareness Month in full swing, AstraZeneca has launched the aMTCSupport.com online resource center to provide information and support specifically designed for people living with advanced medullary thyroid cancer (aMTC) and their loved ones.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7080731-astrazeneca-amtcsupport-resources-for-advanced-medullary-thyroid-cancer/
Alzheimer’s Disease is a disease you might not know a lot about until someone you know has it. It is a progressive disorder where brain cells gradually degenerate and die, causing impairments in memory, learning and mental functioning. In this video you will also learn the 7 stages of Alzheimer’s Disease. http://youtu.be/QCnwJk9lh4g
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
